AKT1 and cancer: It is recognised that THC binds to CB1 and CB2 while CBD acts as an antagonist of GPR55, which cause inhibition of ERK- and AKT-dependent pathways to promote apoptosis and to suppress proliferation of cancer cells [16,17].